
James William Rogers
Examiner (ID: 18141, Phone: (571)272-7838 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1196 |
| Issued Applications | 505 |
| Pending Applications | 144 |
| Abandoned Applications | 587 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19503779
[patent_doc_number] => 12115177
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-10-15
[patent_title] => Application of phenyl glucuronide in preparing drug for pre-warning of cancer via induced volatolomics
[patent_app_type] => utility
[patent_app_number] => 18/518499
[patent_app_country] => US
[patent_app_date] => 2023-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 17
[patent_no_of_words] => 4697
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518499
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/518499 | Application of phenyl glucuronide in preparing drug for pre-warning of cancer via induced volatolomics | Nov 22, 2023 | Issued |
Array
(
[id] => 20213804
[patent_doc_number] => 12410448
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Nanoparticle compositions containing sugar functionalized nucleic acid carriers
[patent_app_type] => utility
[patent_app_number] => 18/516167
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9609
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18516167
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/516167 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | Nov 20, 2023 | Issued |
Array
(
[id] => 19202883
[patent_doc_number] => 20240174782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/503465
[patent_app_country] => US
[patent_app_date] => 2023-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18503465
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/503465 | PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF | Nov 6, 2023 | Abandoned |
Array
(
[id] => 19233705
[patent_doc_number] => 20240190897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS
[patent_app_type] => utility
[patent_app_number] => 18/498744
[patent_app_country] => US
[patent_app_date] => 2023-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18498744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/498744 | NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS | Oct 30, 2023 | Pending |
Array
(
[id] => 18877622
[patent_doc_number] => 20240000991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => ABSORBABLE SUTURE CONTAINING HYALURONIC ACID AND MANUFACTURING METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/368695
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18368695
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/368695 | ABSORBABLE SUTURE CONTAINING HYALURONIC ACID AND MANUFACTURING METHOD THEREFOR | Sep 14, 2023 | Abandoned |
Array
(
[id] => 19814809
[patent_doc_number] => 20250073016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => ORTHOPEDIC ATTACHMENT SYSTEMS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/240138
[patent_app_country] => US
[patent_app_date] => 2023-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18240138
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/240138 | ORTHOPEDIC ATTACHMENT SYSTEMS AND METHODS THEREOF | Aug 29, 2023 | Pending |
Array
(
[id] => 18808584
[patent_doc_number] => 20230382918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => RADIOPHARMACEUTICALS, RADIOIMAGING AGENTS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/233135
[patent_app_country] => US
[patent_app_date] => 2023-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18233135
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/233135 | Radiopharmaceuticals, radioimaging agents, and uses thereof | Aug 10, 2023 | Issued |
Array
(
[id] => 20024785
[patent_doc_number] => 20250163007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => 1,4-BIS-(2-HYDROXY-BENZYL)-1,4,7-TRIAZACYCLONONANE DERIVATIVES AND SIMILAR COMPOUNDS AS LIGANDS IN IRON(III) COMPLEXES FOR USE AS MRI CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/871962
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18871962
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/871962 | 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(III) complexes for use as MRI contrast agents | Jul 27, 2023 | Issued |
Array
(
[id] => 18752555
[patent_doc_number] => 20230355833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => RADIOPAQUE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 18/354109
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18354109
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/354109 | RADIOPAQUE POLYMERS | Jul 17, 2023 | Pending |
Array
(
[id] => 18901475
[patent_doc_number] => 20240016960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => CONJUGATES ENHANCING TOTAL CELLULAR ACCUMULATION
[patent_app_type] => utility
[patent_app_number] => 18/351291
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351291
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/351291 | Conjugates enhancing total cellular accumulation | Jul 11, 2023 | Issued |
Array
(
[id] => 19209576
[patent_doc_number] => 11998612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Method for conjugating antibody and physiologically active substance
[patent_app_type] => utility
[patent_app_number] => 18/338832
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 9676
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18338832
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/338832 | Method for conjugating antibody and physiologically active substance | Jun 20, 2023 | Issued |
Array
(
[id] => 18724449
[patent_doc_number] => 20230338608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => DRESSINGS COMPRISING PLATELET LYSATE
[patent_app_type] => utility
[patent_app_number] => 18/202377
[patent_app_country] => US
[patent_app_date] => 2023-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18202377
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/202377 | DRESSINGS COMPRISING PLATELET LYSATE | May 25, 2023 | Pending |
Array
(
[id] => 18987728
[patent_doc_number] => 20240059697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => COELENTERAZINE ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 18/320633
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18320633
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/320633 | COELENTERAZINE ANALOGUES | May 18, 2023 | Pending |
Array
(
[id] => 18612440
[patent_doc_number] => 20230279172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => RADIOPAQUE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 18/317747
[patent_app_country] => US
[patent_app_date] => 2023-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/317747 | Radiopaque polymers | May 14, 2023 | Issued |
Array
(
[id] => 18595842
[patent_doc_number] => 20230270631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => TOPICAL GLYCOPYRROLATE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/142409
[patent_app_country] => US
[patent_app_date] => 2023-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18142409
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/142409 | TOPICAL GLYCOPYRROLATE FORMULATIONS | May 1, 2023 | Abandoned |
Array
(
[id] => 19297436
[patent_doc_number] => 20240226001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => Contact Lenses And Other Eye-Contacting Matrices Carrying Mitochondrially-Targeted Antioxidants
[patent_app_type] => utility
[patent_app_number] => 18/142017
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18142017
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/142017 | Contact Lenses And Other Eye-Contacting Matrices Carrying Mitochondrially-Targeted Antioxidants | Apr 30, 2023 | Abandoned |
Array
(
[id] => 18626759
[patent_doc_number] => 20230285565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => POLYTETRAFLUOROETHYLENE CO-POLYMER EMULSIONS
[patent_app_type] => utility
[patent_app_number] => 18/130541
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130541
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130541 | POLYTETRAFLUOROETHYLENE CO-POLYMER EMULSIONS | Apr 3, 2023 | Pending |
Array
(
[id] => 18510115
[patent_doc_number] => 20230226216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => METHOD FOR PREPARING CYCLODEXTRIN METAL ORGANIC FRAMEWORK (CD-MOF) STABLE IN AQUEOUS PHASE
[patent_app_type] => utility
[patent_app_number] => 18/187709
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18187709
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/187709 | Method for preparing cyclodextrin metal organic framework (CD-MOF) stable in aqueous phase | Mar 21, 2023 | Issued |
Array
(
[id] => 18953738
[patent_doc_number] => 20240042065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => THERANOSTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/111153
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111153
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/111153 | THERANOSTIC AGENTS | Feb 16, 2023 | Pending |
Array
(
[id] => 19519886
[patent_doc_number] => 12121585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-22
[patent_title] => Dendrimer compositions and methods for drug delivery to the eye
[patent_app_type] => utility
[patent_app_number] => 18/101636
[patent_app_country] => US
[patent_app_date] => 2023-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 20670
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18101636
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/101636 | Dendrimer compositions and methods for drug delivery to the eye | Jan 25, 2023 | Issued |